Ace Blend Secures $9.91 Million for Innovative Nutrition Solutions

Ace Blend, a nutrition startup, has successfully raised $9.91 million in a Series A2 funding round led by 3one4 Capital, with existing investor Fireside Ventures increasing its stake. Fireside Ventures had earlier spearheaded the company’s $3.3 million pre-Series A round. This new infusion of capital is aimed at bolstering research-driven product development and launching novel nutrition formats.

Ace Blend asserts that it experienced a remarkable 300% growth in FY26, with over 46% of its customers returning for additional purchases. Founded by Shivam Hingorani, Ace Blend commenced its product offerings in 2018. In 2022, Saif Mehkri joined as co-founder, contributing nearly thirty years of expertise in the nutrition sector. The company maintains a fully integrated supply chain that encompasses ingredient sourcing, formulation, and manufacturing.

Nutritional Products Backed by Clinical Evidence

Ace Blend creates nutritional products grounded in clinical evidence, emphasising optimal nutrient forms, dosages, and delivery methods. Its product range addresses various health aspects, including heart health, immunity, sleep, recovery, and brain health. Furthermore, the company collaborates with leading global ingredient suppliers DSM and TCI, who have bestowed exclusive rights for specific technologies in India.

Clinical Validation and Quality Assurance

The development of Ace Blend’s products is undertaken by an in-house clinical team and is endorsed by a network of over 400 doctors. To ensure clinical validation and quality control, independent laboratories in Europe conduct automated testing. Additionally, Ace Blend possesses issued patents for innovative nutrition formats tailored for everyday use, with the initial offerings anticipated to launch in the fourth quarter of FY27.